Pluto Bioinformatics

GSE147850: Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted alpha-particle therapy

Bulk RNA sequencing

We used RNA sequencing to analyze the genomic signatures of prostate cancer that progressed after targeted alpha therapy. SOURCE: Robert Klein (robert.klein@mssm.edu) - Icahn School of Medicine at Mount Sinai